{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:01:57Z","timestamp":1758394917597},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T00:00:00Z","timestamp":1299456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1756-0500-4-47","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T07:40:52Z","timestamp":1299570052000},"source":"Crossref","is-referenced-by-count":15,"title":["The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial"],"prefix":"10.1186","volume":"4","author":[{"given":"Alan M","family":"Edwards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,7]]},"reference":[{"key":"803_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1398-9995.2010.01995.x","volume":"65","author":"J Buddenkotte","year":"2010","unstructured":"Buddenkotte J, Steinhoff M: Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy. 2010, 65: 805-821. 10.1111\/j.1398-9995.2010.01995.x.","journal-title":"Allergy"},{"key":"803_CR2","first-page":"115","volume":"5","author":"JS Cox","year":"1970","unstructured":"Cox JS, Beach JE, Blair AM, Clarke AJ, King J, Lee TB, Loveday DE, Moss GF, Orr TS, Ritchie JT, Sheard P: Disodium cromoglycate (Intal). Adv Drug Res. 1970, 5: 115-196.","journal-title":"Adv Drug Res"},{"issue":"6076","key":"803_CR3","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1136\/bmj.1.6076.1570","volume":"1","author":"SA Haider","year":"1977","unstructured":"Haider SA: Treatment of atopic eczema in children: clinical trial of 10% sodium cromoglycate ointment. Br.Med.J. 1977, 1 (6076): 1570-1572. 10.1136\/bmj.1.6076.1570.","journal-title":"Br.Med.J"},{"key":"803_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1365-2133.1985.tb04863.x","volume":"112","author":"M Ariyanayagam","year":"1985","unstructured":"Ariyanayagam M, Barlow TJG, Graham P, Hallsmith SP, Harris JM: Topical sodium cromoglycate in the management of atopic eczema - a controlled trial. Br J Dermatol. 1985, 112: 343-8. 10.1111\/j.1365-2133.1985.tb04863.x.","journal-title":"Br J Dermatol"},{"key":"803_CR5","doi-asserted-by":"crossref","unstructured":"Kimata H, Igarashi M: Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis. Clin Exp Allergy. 1990, 281-283. 10.1111\/j.1365-2222.1990.tb02684.x. 3","DOI":"10.1111\/j.1365-2222.1990.tb02684.x"},{"key":"803_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S1081-1206(10)63145-6","volume":"81","author":"C Moore","year":"1998","unstructured":"Moore C, Ehlayel MS, Junprasert J, Sorensen RU: Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis. Annals Of Allergy Asthma & Immunology. 1998, 81: 452-8.","journal-title":"Annals Of Allergy Asthma & Immunology"},{"issue":"2","key":"803_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2133.2004.06303.x","volume":"152","author":"R Stainer","year":"2005","unstructured":"Stainer R, Matthews S, Arshad SH, McDonald S, Robinson J, Schapira C, Foote KD, Baird-Snell M, Gregory T, Pollock I, Stevens MT, Edwards AM: Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Br J Dermatol. 2005, 152 (2): 334-41. 10.1111\/j.1365-2133.2004.06303.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"803_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2222.1992.tb03102.x","volume":"22","author":"Y Okayama","year":"1992","unstructured":"Okayama Y, Benyon RC, Rees PH, Lowman MA, Hillier K, Church MK: Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy. 1992, 22 (3): 401-409. 10.1111\/j.1365-2222.1992.tb03102.x.","journal-title":"Clin Exp Allergy"},{"issue":"1 Pt 1","key":"803_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0091-6749(83)90540-7","volume":"71","author":"S Ting","year":"1983","unstructured":"Ting S, Zweiman B, Lavker RM: Cromolyn does not modulate human allergic skin reactions in vivo. J Allergy Clin Immunol. 1983, 71 (1 Pt 1): 12-17. 10.1016\/0091-6749(83)90540-7.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"803_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2133.2009.09516.x","volume":"162","author":"R Viera dos Santos","year":"2010","unstructured":"Viera dos Santos R, Magerl M, Martus P, Zuberbier T, Church MK, Escribano L, Maurer M: Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol. 2010, 162 (3): 674-6. 10.1111\/j.1365-2133.2009.09516.x.","journal-title":"Br J Dermatol"},{"key":"803_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/bmj.2.5702.139","volume":"2","author":"JW Kerr","year":"1970","unstructured":"Kerr JW, Govindaraj M, Patel KR: Effect of alpha-receptor blocking dDrugs and disodium cromoglycate on histamine hypersensitivity in bronchial asthma. Brit Med J. 1970, 2: 139-141. 10.1136\/bmj.2.5702.139.","journal-title":"Brit Med J"},{"issue":"6","key":"803_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1365-2125.1983.tb02234.x","volume":"16","author":"JG Collier","year":"1983","unstructured":"Collier JG, Fuller RW: Evidence for an effect of sodium cromoglycate on sensory nerves in man. Br J Clin Pharmac. 1983, 16 (6): 639-43.","journal-title":"Br J Clin Pharmac"},{"issue":"3\/4","key":"803_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF01964987","volume":"18","author":"IM Richards","year":"1986","unstructured":"Richards IM, Dixon M, Jackson DM, Vendy K: Alternative modes of action of sodium cromoglycate. Agents Actions. 1986, 18 (3\/4): 294-300. 10.1007\/BF01964987.","journal-title":"Agents Actions"},{"key":"803_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0703852","volume":"132","author":"P Ahluwalia","year":"2001","unstructured":"Ahluwalia P, McGill JI, Church MK: Nedocromil sodium inhibits histamine-induced itch and flare in human skin. Br J Pharmacol. 2001, 132: 613-5. 10.1038\/sj.bjp.0703852.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"803_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1365-2222.2004.01898.x","volume":"34","author":"EF Willis","year":"2004","unstructured":"Willis EF, Clough GF, Church MK: Investigation into the mechanisms by which nedocromil sodium, frusemide and bumetanide inhibit the histamine-induced itch and flare response in human skin in vivo. Clin Exp Allergy. 2004, 34 (3): 450-455. 10.1111\/j.1365-2222.2004.01898.x.","journal-title":"Clin Exp Allergy"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-4-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-4-47\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-4-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T20:26:32Z","timestamp":1548102392000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-4-47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-4-47","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,7]]},"article-number":"47"}}